Western Blot using CPTC-AKR1B1-1 as primary Ab against Ag 10316 (lane 2). Also included are molecular wt. standards (lane 1) and mouse IgG control (lane 3).
Western Blot using CPTC-AKR1B1-1 as primary Ab against cell lysate from TK-10 cells (lane 2). Also included are molecular wt. standards (lane 1) and mouse IgG control (lane 3).
Indirect ELISA (ie, binding of Antibody to Antigen coated plate)
This table shows cross reactivity within the AKR1 family of antigens.
Protein Array in which CPTC-AKR1B1-1 is screened against the NCI60 cell line panel for expression. Data is normalized to a mean signal of 1.0 and standard deviation of 0.5. Color conveys over-expression level (green), basal level (blue), under-expression (red).
Immuno-histochemistry of CPTC-AKR1B1-1 for NCI60 Cell Line Array at titer 1:500
0=NEGATIVE
1=WEAK(RED)
2=MODERATE(BLUE)
3=STRONG(GREEN)
Tissue Micro-Array(TMA) core of lung cancer showing cytoplasmic staining using Antibody CPTC-AKR1B1-1. Titer: 1:500
This PDF provides the evaluation results as provided by the Human Protein Atlas (www.proteinatlas.org).
This PDF gives the results of Immuno MS with CPTC-AKR1B1-1 and the AKR1B1 antigen.
This file shows the reactivity of the antibody with proteins expressed by the NAPPA technique.
Western Blot using CPTC-AKR1B1-2 as primary Ab against Ag 10316 (lane 2). Also included are molecular wt. standards (lane 1) and mouse IgG control (lane 3).
Western Blot using CPTC-AKR1B1-2 as primary Ab against cell lysate from TK-10 cells (lane 2). Also included are molecular wt. standards (lane 1) and mouse IgG control (lane 3).
Indirect ELISA (ie, binding of Antibody to Antigen coated plate)
This table shows cross reactivity within the AKR1 family of antigens.
Protein Array in which CPTC-AKR1B1-2 is screened against the NCI60 cell line panel for expression. Data is normalized to a mean signal of 1.0 and standard deviation of 0.5. Color conveys over-expression level (green), basal level (blue), under-expression level (red).
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
This PDF provides the results of Immuno MS with CPTC-AKR1B1-2 antibody and AKR1B1 antigen.
This file shows the reactivity of the antibody with proteins expressed by the NAPPA technique.
Western Blot using CPTC-AKR1B1-3 as primary Ab against Ag 10316 (lane 2). Also included are molecular wt. standards (lane 1) and mouse IgG control (lane 3).
Western Blot using CPTC-AKR1B1-3 as primary Ab against cell lysate from TK-10 cells (lane 2). Also included are molecular wt. standards (lane 1) and mouse IgG control (lane 3).
Indirect ELISA (ie, binding of Antibody to Antigen coated plate)
This table shows cross reactivity within the AKR1 family of antigens.
Protein Array in which CPTC-AKR1B1-3 is screened against the NCI60 cell line panel for expression. Data is normalized to a mean signal of 1.0 and standard deviation of 0.5. Color conveys over-expression level (green), basal level (blue), under-expression level (red).
Immuno-histochemistry of CPTC-AKR1B1-3 for NCI60 Cell Line Array at titer 1:250
0=NEGATIVE
1=WEAK
2=MODERATE
3=STRONG
Tissue Micro-Array(TMA) core of lung cancer showing cytoplasmic staining using Antibody CPTC-AKR1B1-3. Titer: 1:250
This PDF provides the evaluation results as provided by the Human Protein Atlas (www.proteinatlas.org).
This PDF provides the results of Immuno MS with CPTC-AKR1B1-3 antibody and AKR1B1 antigen.
This antibody was found to be unsuitable for evaluation by NAPPA because of low reactivity above background.
Get Adobe Reader for free at Adobe.com